Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.

Invivo’s DynaCAD with ONCAD offers a new way of interpreting magnetic resonance imaging (MRI). ONCAD is the first, fully automated morphological analysis system designed to detect suspicious breast lesions as part of a second check during review of contrast enhanced MRI.

Breast Cancer Radiation Therapy Clinical Trial/Study

Breast cancer patients who receive radiation treatment do not have a higher risk of long-term cardiac morbidity when compared to patients undergoing modified radical mastectomy (MRM), according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 54th Annual Meeting. This is the first study to document comprehensive, late cardiac outcomes 25 years after breast cancer treatment.

Concurrent use of sorafenib and stereotactic body radiotherapy (SBRT) for advanced liver cancer patients resulted in high toxicity and is not recommended outside of clinical trials, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 54th Annual Meeting. This is the first prospective study of SBRT combined with sorafenib for hepatocellular carcinoma (HCC) patients, and initial outcomes indicate that the dose of sorafenib and the volume of tissue irradiated are key factors in the risk of toxicity; alternative sequencing of therapies should be investigated in future studies.

The Radiological Society of North America's (RSNA) 98th annual scientific assembly is set for Nov. 25-30, 2012, at McCormick Place in Chicago. The event is the largest radiology meeting in the world, with about 60,000 expected to attend. It includes nearly 3,000 educational sessions as well as hundreds of vendors displaying as part of the technical exhibition.

October 30, 2012 — Civco Medical Solutions announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Protura robotic patient positioning system integration with the AlignRT 3-D imaging system. The FDA also granted approval to integrate the system with Elekta's motion management interface.

Invivo’s NeuroQuant makes integrating functional magnetic resonance imaging (fMRI) plus structural MRI volumetrics into everyday workflow easier so any MR center can utilize these technologies.

October 30, 2012 — IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics announced their first installation of a state-of-the-art, patient-centered proton therapy treatment room in the United States.

October 30, 2012 — MIM Software Inc. announced the availability of MIM 5.6 at the American Society for Radiation Oncology’s (ASTRO’s) 54th Annual Meeting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now